Consistent with these preclinical findings, it was recently shown that longitudinal decline in astrocytosis, as measured by MAO-B expression, was correlated to progressive hypometabolism in autosomal-dominant AD mutation carriers [123], indicating that astrocytes may in part reflect metabolic activity in AD. The gene discussed is MAOB; the disease is Alzheimer disease.